The Exciting Future of Probiotics in Treating Chronic Disease with Deanna Gibson, PhD | MGC Ep. 91
The Mind-Gut Conversation PodcastShow Notes
Inflammatory bowel diseases like ulcerative colitis remain among the most difficult chronic conditions to manage — but new science at the intersection of microbiome research and biotechnology may offer hope.
In this episode of The Mind-Gut Conversation, I sit down with Dr. Deanna Gibson, microbiome researcher and cofounder of Melius Microbiomics, to explore how genetically engineered microbial medicines could transform the future of IBD treatment — and what it will take for patients and the medical community to embrace them.
In this conversation, we explore: · How Dr. Gibson’s research led to the development of BioPersist™ and BioColonize™ for IBD. · Why new microbiome-targeted therapies are urgently needed — especially for younger patients in whom ulcerative colitis is on the rise. · What makes BioPersist™ different from traditional probiotics and current IBD treatments. · How genetically engineered microbial medicines (GEMMs) represent a new generation of gut therapies. · Early research findings that support BioPersist™ as a promising treatment for ulcerative colitis. · Challenges in gaining public trust for novel biotech therapies amid growing skepticism. · Exciting new discoveries in microbiome science — and the future potential for live biotherapeutics beyond IBD.
If you’re curious about the exciting direction where gut health research is headed — and how the microbiome may change the way we treat chronic disease — this episode is for you.
Tune in and join the conversation!
Disclaimer: Dr. Mayer is the Chief Medical Officer of Melius Microbiomics and has been involved in the commercial development of Genetically Engineered Microbial Medicines (GEMMs).
More from The Mind-Gut Conversation Podcast
Nutrition advice seems to change every week, but Dr. Christopher Gardner says the core of what we know has barely moved in fifty years.
Over the past century, average lifespan in Western countries has grown by about 30 years. The years we spend in good health have not kept pace.
After 45 years of research on how the brain and the gut communicate, the question Dr. Emeran Mayer hears most often is not about mechanisms or studies. It is much simpler than that. People tell him they understand the science, they just do not know how to live it.
Modern medicine has never been better at keeping people alive. So why are we spending more of our lives unwell?
For most of the last forty years, irritable bowel syndrome was treated as a problem of the gut alone. The idea that the brain plays a central role took decades to gain acceptance, and it remains contested today.